CHMP decision levels the playing field for GSK's RSV jab
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
Newsletters and Deep Dive digital magazine
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.
Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.
AI-driven customer centricity is built on a continuously learning system that interprets behaviour, identifies intent, and delivers content or support
Editor's Picks
Newsletters and Deep Dive
digital magazine